Staff Writer
The Namibian Competition Commission (NaCC) has approved the acquisition of the Namibian Oncology Centre by Salt Oncology Holdings without conditions.
Salt Oncology Holdings will take over 100% of the shares in the Namibian Oncology Centre.
The acquiring group includes Salt Equity, FISEA and Jan Bosch Investment Limited.
Salt Equity is managed by Salt Capital GP Ltd and focuses on investing in businesses across the Southern African Development Community.
FISEA is controlled by Agence Française de Développement and supports job creation and economic growth in Africa. Jan Bosch Investment Limited invests in mid-sized companies across the continent.
In Namibia, the group already has investments through Salt Investment Holdings.
These include Medfam Holdings, which operates Rhino Park Private Hospital, as well as the Welwitschia Hospital Group.
The group’s portfolio also includes Walvis Bay Medipark, Erongo Radiology, Otjiwarongo Medical Services, Medipark Equipment Rental and Specscare Namibia, covering hospital services, imaging, equipment and rehabilitation care.
The Namibian Oncology Centre is a private healthcare provider that focuses on cancer treatment.
It offers radiation and clinical oncology, chemotherapy, paediatric oncology, pharmacy services, inpatient care, diagnostics, counselling and rehabilitation.
NaCC classified the deal as a conglomerate merger. It defined the market as specialised oncology services in Namibia.
After reviewing the transaction, NaCC said the deal is unlikely to reduce competition or create a dominant market position.
It also found no public interest concerns and approved the merger without conditions.
Caption
Namibian Oncology Centre has been bought by Salt Oncology Holdings (SPV).
- Photo: Contributed
